Praram 9 Hospital (PR9) expects its performance in the second half of 2026 to be better than the first half, with full-year total revenue growing at a mid-single-digit rate, driven by the return of foreign patients, especially from the Middle East. Meanwhile, the Myanmar market remains strong, and China is starting to recover in Q4 2026. The hospital is also entering the Indonesian market through health fairs and focusing on complex diseases to increase margins. In Q2 2026, the proportion of revenue from foreign patients reached 29%, with an average profit margin of 13-14%. Additionally, it is expanding its healthcare ecosystem by supporting startups.
Praram 9 Hospital Public Company LimitedReturn of foreign patients, especially from Middle East, and recovery in China boost revenue growth.
